Targeting pancreatic cancer stem cells for cancer therapy

详细信息    查看全文

• 作者：Jun Xia ; Changjie Chen ; Zhiwen Chen ; Lucio Miele ; Fazlul H. Sarkar ; Zhiwei Wang
• 关键词：Pancreatic cancer ; Stem cell ; Natural agents ; Cancer therapy
• 刊名：Biochimica et Biophysica Acta (BBA)/Reviews on Cancer
• 出版年：2012
• 出版时间：December, 2012
• 年：2012
• 卷：1826
• 期：2
• 页码：385-399
• 全文大小：563 K

文摘

Pancreatic cancer (PC) is the fourth most frequent cause of cancer death in the United States. Emerging evidence suggests that pancreatic cancer stem cells (CSCs) play a crucial role in the development and progression of PC. Recently, there is increasing evidence showing that chemopreventive agents commonly known as nutraceuticals could target and eliminate CSCs that have been proposed as the root of the tumor progression, which could be partly due to attenuating cell signaling pathways involved in CSCs. Therefore, targeting pancreatic CSCs by nutraceuticals for the prevention of tumor progression and treatment of PC may lead to the development of novel strategy for achieving better treatment outcome of PC patients. In this review article, we will summarize the most recent advances in the pancreatic CSC field, with particular emphasis on nutraceuticals that target CSCs, for fighting this deadly disease.